Apollo Endosurgery, Inc. (APEN) financial statements (2022 and earlier)

Company profile

Business Address 1120 SOUTH CAPITAL OF TX HWY
AUSTIN, TX 78746
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments90,69136,23529,90523,99630,51319,1118,890
Cash and cash equivalents90,69136,23529,90523,99630,51319,1118,890
Receivables10,0788,2189,23211,39111,72910,5097
Inventory, net of allowances, customer advances and progress billings11,96610,3068,8659,93214,34312,163 
Inventory11,96610,3068,8659,93214,34312,163 
Other undisclosed current assets1,9653,7712,9982,8011,0151,838357
Total current assets:114,70058,53051,00048,12057,60043,6219,254
Noncurrent Assets
Property, plant and equipment  6,6125,8976,8856,889149
Intangible assets, net (including goodwill)9,69011,30713,12115,14943,24950,1432,132
Goodwill5,2905,2905,2905,2906,8286,828 
Intangible assets, net (excluding goodwill)4,4006,0177,8319,85936,42143,3152,132
Restricted cash and investments1,1219651,0161,011905930 
Other noncurrent assets4244142,8334,29142254177
Other undisclosed noncurrent assets5,5936,221     
Total noncurrent assets:16,82818,90723,58226,34851,46158,5032,359
TOTAL ASSETS:131,52877,43774,58274,468109,061102,12411,612
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14,48611,03218,34024,44825,82711,7751,045
Accounts payable4,5843,6759,90215,29218,3275,145294
Accrued liabilities9,9027,3578,4389,1567,5006,630204
Employee-related liabilities      547
Debt 63634,449    
Due to related parties     8,505 
Deferred revenue and credits  36
Total current liabilities:14,48611,66852,78924,44825,82720,2801,080
Noncurrent Liabilities
Long-term debt and lease obligation52,98656,57918,55421,19033,32139,427 
Long-term debt, excluding current maturities52,98656,57918,55421,19033,32139,427 
Liabilities, other than long-term debt2,8192,439     
Other liabilities2,8192,439     
Other undisclosed noncurrent liabilities  1,116    
Total noncurrent liabilities:55,80559,01819,67021,19033,32139,427 
Total liabilities:70,29170,68672,45945,63859,14859,7071,080
Stockholders' equity
Stockholders' equity attributable to parent61,2376,7512,12328,83049,91342,41710,532
Common stock40262122171133
Additional paid in capital356,516276,569250,634249,115225,122190,66486,542
Accumulated other comprehensive income2,1362,9291,6302,5011,7951,471 
Accumulated deficit(297,455)(272,773)(250,162)(222,808)(177,021)(149,729)(76,044)
Total stockholders' equity:61,2376,7512,12328,83049,91342,41710,532
TOTAL LIABILITIES AND EQUITY:131,52877,43774,58274,468109,061102,12411,612

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues62,98942,04850,71360,85464,31064,8681,600
Cost of revenue(28,030)(19,806)(25,038)(27,660)(24,578)(25,255) 
Gross profit:34,95922,24225,67533,19439,73239,6131,600
Operating expenses(54,158)(38,036)(49,188)(73,287)(62,171)(60,374)(12,460)
Operating loss:(19,199)(15,794)(23,513)(40,093)(22,439)(20,761)(10,860)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
139(1,424)408(1,440)(41)(1,851)0
Interest and debt expense(8,318)(5,251)(4,052)(4,063)(4,508)(18,168) 
Loss from continuing operations before equity method investments, income taxes:(27,378)(22,469)(27,157)(45,596)(26,988)(40,780)(10,860)
Other undisclosed income from continuing operations before income taxes2,852      
Loss from continuing operations before income taxes:(24,526)(22,469)(27,157)(45,596)(26,988)(40,780)(10,860)
Income tax expense(156)(142)(275)(191)(304)(387) 
Net loss attributable to parent:(24,682)(22,611)(27,432)(45,787)(27,292)(41,167)(10,860)
Other undisclosed net income available to common stockholders, basic      850
Net loss available to common stockholders, diluted:(24,682)(22,611)(27,432)(45,787)(27,292)(41,167)(10,010)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(24,682)(22,611)(27,432)(45,787)(27,292)(41,167)(10,860)
Comprehensive loss:(24,682)(22,611)(27,432)(45,787)(27,292)(41,167)(10,860)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(793)1,299(871)7063241,463 
Comprehensive loss, net of tax, attributable to parent:(25,475)(21,312)(28,303)(45,081)(26,968)(39,704)(10,860)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: